This review highlights the clinical and economic impact of 30-day readmissions in COPD patients and describes key risk factors to predict readmission.
High 30-day COPD readmission rates warrant better discharge strategies; Level 5 predictors leave open targeted prospective trials.
Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease worldwide; acute exacerbation of chronic obstructive pulmonary disease is a clinical condition characterized by a worsening of the patient’s respiratory signs and symptoms, reducing the overall life expectancy. Readmission in a period of 30 days or less after discharge represents a new emerging clinical condition. In COPD patients, the rate of a 30-day readmission is reported to be approximately 20%; high rates of readmission may result from patients’ complexity or from the complexity of the hospital system. Because a 30-day readmission has both clinical and economic impact, there is considerable interest in searching for factors that can predict readmission of COPD patients. In this paper, we describe the most important risk factors linked to readmission in a period of 30 days or less after discharge, and their role in the context of problems relating to readmission, in COPD patients primarily hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
No takes yet. Share an insight, caveat, or question.
Crisafulli et al. (2015) studied this question.